- Home
- ENLV vs SY Comparison
ENLV vs SY Comparison
Compare ENLV & SY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENLV | SY |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.3M | 283.0M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ENLV | SY |
|---|---|---|
| Price | $1.16 | $2.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $13.00 | $5.50 |
| AVG Volume (30 Days) | 466.5K | ★ 566.8K |
| Earning Date | 03-30-2026 | 11-17-2025 |
| Dividend Yield | N/A | ★ 0.90% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $201,132,009.00 |
| Revenue This Year | N/A | $6.36 |
| Revenue Next Year | N/A | $57.24 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.66 | $0.67 |
| 52 Week High | $2.10 | $6.28 |
Technical Indicators
Market Signals| Indicator | ENLV | SY |
|---|---|---|
| Relative Strength Index (RSI) | 62.69 | 53.49 |
| Support Level | $1.01 | $2.78 |
| Resistance Level | $1.26 | $3.14 |
| Average True Range (ATR) | 0.09 | 0.21 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 66.17 | 47.10 |
Price Performance
Historical ComparisonAbout ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About SY So-Young International Inc. American Depository Shares
So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.